Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163746OMIM:609136E75.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH) is an extremely rare and severe neurocristopathy caused by mutations in the SOX10 gene. It is considered a complex variant of Waardenburg-Shah syndrome (Waardenburg syndrome type 4C) and combines features of four distinct conditions. The disorder affects multiple body systems derived from neural crest cells, including the peripheral nervous system, central nervous system, skin and hair pigmentation, the inner ear, and the enteric nervous system of the gastrointestinal tract. Key clinical features include peripheral demyelinating neuropathy (damage to the myelin sheath of peripheral nerves causing weakness and sensory loss), central dysmyelinating leukodystrophy (abnormal formation of myelin in the brain and spinal cord leading to neurological impairment), features of Waardenburg syndrome (sensorineural hearing loss, heterochromia iridis, white forelock, and other pigmentary abnormalities), and Hirschsprung disease (absence of ganglion cells in segments of the colon causing functional bowel obstruction). Patients typically present in the neonatal period with a combination of these features, and the neurological involvement tends to be progressive and severe. There is currently no cure or disease-specific therapy for PCWH. Management is supportive and multidisciplinary, involving surgical intervention for Hirschsprung disease (such as pull-through procedures), hearing aids or cochlear implants for sensorineural deafness, physical therapy and rehabilitation for neuropathy, and neurological monitoring for central nervous system involvement. Genetic counseling is recommended for affected families. The prognosis varies but is generally guarded due to the severity of neurological complications.

Also known as:

Clinical phenotype terms— hover any for plain English:

IleusHP:0002595
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

View clinical trials →

No actively recruiting trials found for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease community →

No specialists are currently listed for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung diseaseForum →

No community posts yet. Be the first to share your experience with Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

Start the conversation →

Latest news about Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease

No recent news articles for Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease

What is Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease?

Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease (PCWH) is an extremely rare and severe neurocristopathy caused by mutations in the SOX10 gene. It is considered a complex variant of Waardenburg-Shah syndrome (Waardenburg syndrome type 4C) and combines features of four distinct conditions. The disorder affects multiple body systems derived from neural crest cells, including the peripheral nervous system, central nervous system, skin and hair pigmentation, the inner ear, and the enteric nervous system of the gastrointestinal trac

How is Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease inherited?

Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease typically begin?

Typical onset of Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease is neonatal. Age of onset can vary across affected individuals.